Subscribe to Newsletter
Discovery & Development Clinical Trials
GLP-1s: Going Beyond Diabetes and Obesity

| 4 min read

What other therapeutic indications could GLP-1s make an impact in? We take a look at the research to find out.

Business & Regulation Business Practice

This Week’s Biopharma News: RFK Jr Selects New Members for US Vaccine Committee

| 4 min read

Our latest news roundup reports on a new RSV FDA approval for Moderna, payment hikes in the UK, and calls in the US for a ban on direct-to-consumer advertising.

Discovery & Development Drug Discovery

Breaking Barriers: A New Approach for Targeted Drug Delivery to the Brain

| 5 min read

A new approach to tackling the blood-brain barrier is attracting attention from big pharma.

Business & Regulation Advanced Medicine

Gene Therapy Successes in Ophthalmology

| Daniel Eisenman, James Riddle | 8 min read

Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.

Register to personalize your newsfeed
Create Account

Latest Articles

 Business & Regulation Standards & Regulation

FDA Plans for Shorter Drug Reviews

| Kerri Miller | 2 min read

Martin A. Makary and Vinay Prasad write that “rapid or instant reviews” could be possible at the FDA.
Manufacture Advanced Medicine

This Week’s CGT News: Sarepta Gets FDA Platform Technology Designation

| 4 min read

Our latest news roundup reports on dysfunction observed in edited blood stem cells, and RFK Jr’s support for experimental treatments.
Manufacture Advanced Medicine

Using Machine Learning to Improve Gene Therapy Design

| Stephanie Vine | 2 min read

Stanford University researchers explore how zinc fingers can enhance gene therapy.
Business & Regulation Standards & Regulation

RFK Jr Fires CDC Vaccine Advisory Committee

| Stephanie Vine | 3 min read

All 17 members removed from advisory panel, with RFJ Jr claiming it is “plagued with conflict of interest.”
Manufacture Bioprocessing - Upstream & Downstream

Advances and Opportunities in Biologics Formulation

| Heonchang Lim, Derrick Katayama | 2 min read

The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.
Discovery & Development Formulation

Can AI Help Solve the Solubility Challenge?

| 10 min read

We explore how AI-based tools are making a mark in formulation by improving solubility.
Discovery & Development Small Molecules

Navigating the Therapeutic Landscape of GERD

| Rob Coker | 2 min read

A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.
Business & Regulation Business Practice

This Week’s Biopharma News: Argentina’s WHO Exit and Sanofi Acquisition of Blueprint Medicines

| Rob Coker | 4 min read

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
Business & Regulation Advanced Medicine

Preparing National Strategies for CAR T: The Latest IQVIA Report

| Rob Coker | 5 min read

The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies
Manufacture Facilities

Worst-Case Scenarios and Ideal Facilities in Fill-Finish

| Stephanie Vine | 7 min read

Is the complexity of the fill-finish process under appreciated in pharma manufacturing? Four experts discuss why it’s important to get it right.
All Articles
Discovery & Development Clinical Trials

How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials

Manufacture Advanced Medicine

This Week’s CGT News: Investigating the Long-Term Safety of Gene Therapy for Hemophilia B

Manufacture Vaccines

The Front Lines of Tuberculosis Vaccine Research

Upcoming Events

-
PDA Virus Conference 2025 | PDA

Gothenburg, Sweden

The PDA Virus Conference 2025, held in Gothenburg, Sweden on 24-25 June 2025, will focus on "Modernization of Viral...
-
Sartorius PI Forum 2025

Boston, MA, USA

Meet us at the Sartorius PI Forum at the Royal Sonesta Boston, where industry leaders will meet to discuss the latest...
-
PDA Advanced Therapy Medicinal Products Conference 2025 | PDA

Gothenburg, Sweden

The PDA Advanced Therapy Medicinal Products Conference 2025, held in Gothenburg, Sweden on 26-27 June 2025, will explore...
Event
-
PDA Virus Conference 2025 | PDA

Gothenburg, Sweden

The PDA Virus Conference 2025, held in Gothenburg, Sweden on 24-25 June 2025, will focus on "Modernization of Viral Safety for Biologics." This event brings together industry experts to discuss breakthroughs in virus detection, safety strategies, and regulatory advancements, offering valuable insights and networking opportunities.

More information

Event
-
Sartorius PI Forum 2025

Boston, MA, USA

Meet us at the Sartorius PI Forum at the Royal Sonesta Boston, where industry leaders will meet to discuss the latest advancements and future needs in process intensification (PI) for proteins and new modalities. This exclusive event will explore key topics like flexible manufacturing, digitalization, automation, and sustainability — as well as new solutions that are driving more efficient, scalable, and sustainable biomanufacturing.  

Engage in data-driven presentations by 20 industry experts from Lonza, Sanofi, AstraZeneca, Merck and many more. Join tours in new Sartorius Center for Bioprocess Innovation and Amgen, and enjoy workshops, and interactive demonstrations to gain valuable insights into cutting-edge technologies and successful PI strategies that are shaping the future of the biopharmaceutical industry.

More information

Event
-
PDA Advanced Therapy Medicinal Products Conference 2025 | PDA

Gothenburg, Sweden

The PDA Advanced Therapy Medicinal Products Conference 2025, held in Gothenburg, Sweden on 26-27 June 2025, will explore "The Renaissance of Medicine: ATMPs and Maturing Perspectives." Delve into breakthroughs, manufacturing challenges, regulatory updates, quality control strategies, and the clinical impact of ATMPs.

More information

All Events

Sister Publications

You might be interested in our Sister Publications:

Latest White Papers

Viral Safety and Viral Clearance Summit Takeaways

| Contributed by Charles River

Single ingredient optimization supports the expansion of pluripotent stem cells

| Contributed by Novo Nordisk

Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

Ploughshare® Mixer for batch operation in pharmaceutical production: well-established all-rounder

| Contributed by Lodige

All White Papers

Webinars on Demand

Discovery & Development Drug Discovery

Unlocking the Potential of Tricyclic Peptides – Antibody-Like Precision with Peptide Therapeutics

| Sponsored by Biosynth

Join us for an exclusive session on CLIPS™ multicycles, a novel class of constrained tricyclic peptides with enormous potential as next-generation peptide therapeutics.
Manufacture Bioprocessing - Single Use Systems

Bioprocessing Revisited: Applying the Lessons from mAbs Production to Advanced Therapeutics Manufacturing

| Sponsored by Merck

This roundtable will explore the challenges manufacturers face in this digital age as well as the new technologies and innovations that are setting the standard for the future
Manufacture Advanced Medicine

Empowering you to master control, predictability, and efficiency, partnering in your digital transformation

| Sponsored by Repligen

Join a panel of experts from Repligen as we discuss how the lessons learned from monoclonal antibodies (mAbs) production can be applied to advanced therapeutic medicinal products (ATMPs)
All Webinars

Most popular articles

1. Manufacture Advanced Medicine

This Week’s CGT News: Investigating the Long-Term Safety of Gene Therapy for Hemophilia B

| 4 min read

Our latest news roundup reports on CAR t cell therapy at J&J and a second patient death linked to a Sarepta gene therapy.
2. Business & Regulation Business Practice

This Week’s Biopharma News: RFK Jr Selects New Members for US Vaccine Committee

| 4 min read

Our latest news roundup reports on a new RSV FDA approval for Moderna, and calls in the US for a ban on direct-to-consumer advertising.
3. Discovery & Development Clinical Trials

How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials

| Allison Cuff Shimooka | 7 min read

During the COVID-19 pandemic, significant progress was made in improving clinical trials. But there are now signs of backsliding.
4. Manufacture Advanced Medicine

Time Machine

| Sponsored by Eppendorf, Marken, Sartorius

Step into a future where science fiction meets reality – the world of cell and gene therapies.
5. Business & Regulation Standards & Regulation

FDA Plans for Shorter Drug Reviews

| Kerri Miller | 2 min read

Martin A. Makary and Vinay Prasad write that “rapid or instant reviews” could be possible at the FDA.
Discovery & Development
Clinical Trials

GLP-1s: Going Beyond Diabetes and Obesity

| 4 min read

What other therapeutic indications could GLP-1s make an impact in? We take a look at the research to find out.
Drug Discovery

Breaking Barriers: A New Approach for Targeted Drug Delivery to the Brain

| 5 min read

A new approach to tackling the blood-brain barrier is attracting attention from big pharma.
Clinical Trials

How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials

| Allison Cuff Shimooka | 7 min read

During the COVID-19 pandemic, significant progress was made in improving clinical trials. But there are now signs of backsliding.
Manufacture
Advanced Medicine

This Week’s CGT News: Investigating the Long-Term Safety of Gene Therapy for Hemophilia B

| 4 min read

Our latest news roundup reports on CAR t cell therapy at J&J and a second patient death linked to a Sarepta gene therapy.
Advanced Medicine

This Week’s CGT News: Sarepta Gets FDA Platform Technology Designation

| 4 min read

Our latest news roundup reports on dysfunction observed in edited blood stem cells, and RFK Jr’s support for experimental treatments.
Vaccines

The Front Lines of Tuberculosis Vaccine Research

| Stephanie Vine | 10 min read

There has been no new TB vaccine for over 100 years, but a candidate in phase III has just finished enrolling the target of 20,000 participants.

Business & Regulation
Business Practice

This Week’s Biopharma News: RFK Jr Selects New Members for US Vaccine Committee

| 4 min read

Our latest news roundup reports on a new RSV FDA approval for Moderna, and calls in the US for a ban on direct-to-consumer advertising.
Advanced Medicine

Gene Therapy Successes in Ophthalmology

| Daniel Eisenman, James Riddle | 8 min read

Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.
Standards & Regulation

FDA Plans for Shorter Drug Reviews

| Kerri Miller | 2 min read

Martin A. Makary and Vinay Prasad write that “rapid or instant reviews” could be possible at the FDA.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker